Among potential effective anticancer treatments, TRAIL (TNFα-related apoptosis inducing ligand) is a promising anti-neoplastic agent because it induces apoptosis in cancer cells with only negligible effect on normal cells [12]. The gene discussed is TNFSF10; the disease is cancer.